Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England

BACKGROUND: In patients with type 2 diabetes, hyperglycaemia is an independent risk factor for COVID-19-related mortality. Associations between pre-infection prescription for glucose-lowering drugs and COVID-19-related mortality in people with type 2 diabetes have been postulated but only investigat...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Lancet Diabetes Endocrinol
Auteurs principaux: Khunti, Kamlesh, Knighton, Peter, Zaccardi, Francesco, Bakhai, Chirag, Barron, Emma, Holman, Naomi, Kar, Partha, Meace, Claire, Sattar, Naveed, Sharp, Stephen, Wareham, Nicholas J, Weaver, Andy, Woch, Emilia, Young, Bob, Valabhji, Jonathan
Format: Artigo
Langue:Inglês
Publié: Elsevier Ltd. 2021
Sujets:
Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8009618/
https://ncbi.nlm.nih.gov/pubmed/33798464
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2213-8587(21)00050-4
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires